Selective DNA delivery to tumor cells using an oligoarginine-LTVSPWY peptide

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Gong, Cheng ^a,b   Pan, Deng ^a,b   Qiu, Fengwu ^a,b   Sun, Pei ^a,b   Zhang, Yu Hui ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGOARGINYLLEUCYLTHREONYLVALYLSERYLPROLYLTRYPTOPHANYLTYROSINE PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; CELL PENETRATING PEPTIDE; OLIGOPEPTIDE; PEPTIDE; POLYARGININE;

ADSORPTION KINETICS; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL LINE; CANCER GENE THERAPY; CONTROLLED STUDY; DNA BINDING; DNA TRANSFECTION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG TARGETING; DRUG UPTAKE; EXPRESSION VECTOR; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; SOLID PHASE SYNTHESIS; STATIC ELECTRICITY; TARGET CELL; ZETA POTENTIAL; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEOPLASMS; PLASMID; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; GENETIC THERAPY; HUMANS; NEOPLASMS; OLIGOPEPTIDES; PEPTIDES; PLASMIDS; TRANSFECTION;

EID: 84908433129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110632     Document Type: Article

References (34)

1. Münch RC, Janicki H, Völker I, Rasbach A, Hallek M, et al. (2013) Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer. Mol Ther 21: 109-118.
2. Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-39.
3. Huang S, Kamihira M (2012) Development of hybrid viral vectors for gene therapy. Biotechnol Adv 31: 208-223.
4. He H, Kong SK, Chan KT (2011) Transfection and cell fusion by femtosecond lasers. J Innov Opt Health Sci 04: 113-125.
5. Lehrman S (1999) Virus treatment questioned after gene therapy death. Nature 401: 517-518.
6. Kim PH, Kim T, Yockman JW, Kim SW, Yun CO (2010) The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 31: 1865-1874.
7. Lv H, Zhang S, Wang B, Cui S, Yan J (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 114: 100-109.
8. Zhang Y, Satterlee A, Huang L (2012) In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles&quest. Mol Ther 20: 1298-1304.
9. Martin ME, Rice KG (2007) Peptide-guided gene delivery. AAPS J 9: 18-29.
10. Seow WY, Yang YY, George AJT (2009) Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res 37: 6276-6289.
11. Sadatmousavi P, Soltani M, Nazarian R, Jafari M, Chen P (2011) Self-assembling peptides: potential role in tumor targeting. Curr Pharm Biotechnol 12: 1089-1100.
12. Standley SM, Toft DJ, Cheng H, Soukasene S, Chen J, et al. (2010) Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res 70: 3020-3026.
13. Ruoslahti E (2012) Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater 24: 3747-3756.
14. Fonseca SB, Pereira MP, Kelley SO (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliver Rev 61: 953-964.
15. Nakase I, Akita H, Kogure K, Graslund A, Langel Ul, et al. (2012) Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Account Chem Res 45: 1132-1139.
16. Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH (2008) The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliver Rev 60: 452-472.
17. Wang HY, Chen JX, Sun YX, Deng JZ, Li C, et al. (2010) Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. J Control Release 155: 26-33.
18. Khalil I, Futaki S, Niwa M, Baba Y, Kaji N, et al. (2004) Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 11: 636-644.
19. Seow WY, Yang YY (2009) A Class of Cationic Triblock Amphiphilic Oligopeptides as Efficient Gene-Delivery Vectors. Adv Mater 21: 86-90.
20. Liu L, Zheng M, Renette T, Kissel T (2012) Modular Synthesis of Folate Conjugated Ternary Copolymers: Polyethylenimine-graft-Polycaprolactone-block-Poly (ethylene glycol)-Folate for Targeted Gene Delivery. Bioconjugate Chem 23: 1211-1220.
21. Minko T (2012) Receptor Mediated Delivery Systems for Cancer Therapeutics. Fundamentals and Applications of Controlled Release Drug Delivery. US: Springer 329-355 p.
22. Shadidi M, Sioud M (2003) Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J 17: 256-258.
23. Luo H, Yang J, Jin H, Huang C, Fu J, et al. (2011) Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo. FASEB J 25: 1865-1873.
24. Gong C, Li X, Xu L, Zhang YH (2012) Target delivery of a gene into the brain using the RVG29-oligoarginine peptide. Biomaterials 33: 3456-3463.
25. Song L, Yan J, Jian S, Zhang L, Li M, et al. (2002) Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines. Ai Zheng 21: 158-162.
26. Ma Y, Gong C, Ma Y, Fan F, Luo M, et al. (2012) Direct Cytosolic Delivery of Cargoes in vivo by a Chimera Consisting of D-and L-Arginine Residues. J Control Release 162: 286-294.
27. Wang XF, Birringer M, Dong LF, Veprek P, Low P, et al. (2007) A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Res 67: 3337-3344.
28. Won YW, Kim HA, Lee M, Kim YH (2009) Reducible poly (oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther 18: 734-742.
29. Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3: 145-150.
30. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, et al. (2007) Renal clearance of quantum dots. Nat Biotechnol 25: 1165-1170.
31. Wang S, Song H, Ong WY, Han MY, Huang D (2009) Positively charged and pH self-buffering quantum dots for efficient cellular uptake by charge mediation and monitoring cell membrane permeability. Nanotechnology 20: 425102-425109.
32. Chi EY, Krishnan S, Randolph TW, Carpenter JF (2003) Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 20: 1325-1336.
33. Henriques ST, Melo MN, Castanho MARB (2006) Cell-penetrating peptides and antimicrobial peptides: how different are they? BioChem J 399: 1-7.
34. El-Sayed A, Khalil IA, Kogure K, Futaki S, Harashima H (2008) Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 283: 23450-23461.